Ajanta Pharma to meet for buyback

Our Bureau Chennai | Updated on October 28, 2020


The board of directors of Ajanta Pharma will meet on November 3 to consider the unaudited consolidated and financial results for the quarter and half year ended September 30, 2020, and interim dividend. It will also consider a proposal for buy-back of the equity shares of the company and any other matter as the board may decide during the course of the meeting, it said in a notice to the stock exchanges. Shares of Ajanta Pharma closed 1.18 per cent at ₹1,589.55 on the BSE.

Published on October 28, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like